Aprea Therapeutics Inc (APRE)

3.72 -0.18  -4.62% NASDAQ Dec 3, 12:24 USD
View Full Chart
Price Chart
View All APRE News

News

View All Events

Events

Date Type Description
03/16/2022 Earnings Results Q4 2021 Earnings Results
11/08/2021 Earnings Results Q3 2021 Earnings Results
08/12/2021 Earnings Results Q2 2021 Earnings Results
06/09/2021 09:00 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
03/16/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
  • URL: https://www.aprea.com
  • Investor Relations URL: N/A
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Mar. 16, 2022
  • Last Earnings Release: Nov. 08, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.